Sensitivity and Specificity of a Urine Circulating Anodic Antigen Test for the Diagnosis of Schistosoma haematobium in Low Endemic Settings

PLoS Neglected Tropical Diseases

Volumn 9, Issue 5, 2015, Pages

  Knopp, Stefanie ^a,b,c   Corstjens, Paul L A M ^d   Koukounari, Artemis ^e   Cercamondi, Colin I ^f   Ame, Shaali M ^g   Ali, Said M ^g   de Dood, Claudia J ^d   Mohammed, Khalfan A ^h   Utzinger, Jürg ^b,c   Rollinson, David ^a   van Dam, Govert J ^d  

^a DEPARTMENT OF LIFE SCIENCES   (United Kingdom)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f ETH ZURICH   (Switzerland)

^g Public Health Laboratory Ivo de Carneri   (Tanzania)

^h Elderly and Children   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASSAY; CHILD; FEMALE; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SCHISTOSOMIASIS HAEMATOBIA; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; URINALYSIS; URINE BASED UP CONVERTING PHOSPHOR LATERAL FLOW CIRCULATING ANODIC ANTIGEN ASSAY; ANIMAL; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; INDIAN OCEAN; INFANT; PRESCHOOL CHILD; PROCEDURES; SCHISTOSOMA HAEMATOBIUM; TANZANIA; URINE;

CIRCULATING ANODIC ANTIGEN, SCHISTOSOMA MANSONI; GLYCOPROTEIN; HELMINTH PROTEIN; PARASITE ANTIGEN;

ANIMALS; ANTIGENS, HELMINTH; CHILD; CHILD, PRESCHOOL; GLYCOPROTEINS; HELMINTH PROTEINS; HUMANS; IMMUNOLOGIC TESTS; INDIAN OCEAN ISLANDS; INFANT; MALE; PREVALENCE; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; SENSITIVITY AND SPECIFICITY; TANZANIA; URINALYSIS;

EID: 84929371325     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003752     Document Type: Article

References (49)

1. Utzinger J, Keiser J, Research and development for neglected diseases: more is still needed, and faster. Lancet Glob Health. 2013;1: e317. doi: 10.1016/S2214-109X(13)70148-7 25104587
2. Molyneux DH, Neglected tropical diseases: now more than just 'other diseases'—the post-2015 agenda. Int Health. 2014;6: 172–180. doi: 10.1093/inthealth/ihu037 24969646
3. Multiple Partners. Uniting to combat neglected tropical diseases. Ending the neglect & reaching 2020 goals. Table of commitments. London, United Kingdom. 30 January 2012. Available: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/67442/NTD_20Event_20-_20Table_20of_20Commitments.pdf. Accessed: 14 April 2015.
4. Stothard JR, Stanton MC, Bustinduy AL, Sousa-Figueiredo JC, van Dam GJ, Betson M, et al. Diagnostics for schistosomiasis in Africa and Arabia: a review of present options in control and future needs for elimination. Parasitology. 2014;141: 1947–1961. doi: 10.1017/S0031182014001152 25158604
5. WHO. Schistosomiasis: progress report 2001–2011 and strategic plan 2012–2020. Geneva: World Health Organization; 2013. pp 1–80.
6. Rollinson D, Knopp S, Levitz S, Stothard JR, Tchuem Tchuenté LA, Garba A, et al. Time to set the agenda for schistosomiasis elimination. Acta Trop. 2013;128: 423–440. doi: 10.1016/j.actatropica.2012.04.013 22580511
7. Utzinger J, Raso G, Brooker S, de Savigny D, Tanner M, Ornbjerg N, et al. Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution. Parasitology. 2009;136: 1859–1874. doi: 10.1017/S0031182009991600 19906318
8. WHO. Neglected tropical diseases. Prevention, control, elimination and eradication. Provisional agenda item 9.2. Geneva: World Health Organization; 2012. pp 1–10.
9. Grimes JET, Croll D, Harrison WE, Utzinger J, Freeman MC, Templeton MR, The relationship between water, sanitation and schistosomiasis: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2014;8: e3296. doi: 10.1371/journal.pntd.0003296 25474705
10. King CH, Toward the elimination of schistosomiasis. N Engl J Med. 2009;360: 106–109. doi: 10.1056/NEJMp0808041 19129524
11. Bergquist R, Johansen MV, Utzinger J, Diagnostic dilemmas in helminthology: what tools to use and when? Trends Parasitol. 2009;25: 151–156. doi: 10.1016/j.pt.2009.01.004 19269899
12. Lustigman S, Prichard RK, Gazzinelli A, Grant WN, Boatin BA, McCarthy JS, et al. A research agenda for helminth diseases of humans: the problem of helminthiases. PLoS Negl Trop Dis. 2012;6: e1582. doi: 10.1371/journal.pntd.0001582 22545164
13. Katz N, Chaves A, Pellegrino J, A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop São Paulo. 1972;14: 397–400.
14. Peters PA, Mahmoud AA, Warren KS, Ouma JH, Siongok TK, Field studies of a rapid, accurate means of quantifying Schistosoma haematobium eggs in urine samples. Bull World Health Organ. 1976;54: 159–162. 1088097
15. King CH, Bertsch D, Meta-analysis of urine heme dipstick diagnosis of Schistosoma haematobium infection, including low-prevalence and previously-treated populations. PLoS Negl Trop Dis. 2013;7: e2431. doi: 10.1371/journal.pntd.0002431 24069486
16. Booth M, Vounatsou P, N'Goran EK, Tanner M, Utzinger J, The influence of sampling effort and the performance of the Kato-Katz technique in diagnosing Schistosoma mansoni and hookworm co-infections in rural Côte d'Ivoire. Parasitology. 2003;127: 525–531. 14700188
17. Koukounari A, Donnelly CA, Moustaki I, Tukahebwa EM, Kabatereine NB, Wilson S, et al. A latent Markov modelling approach to the evaluation of circulating cathodic antigen strips for schistosomiasis diagnosis pre- and post-praziquantel treatment in Uganda. PLoS Comput Biol. 2013;9: e1003402. doi: 10.1371/journal.pcbi.1003402 24367250
18. McCarthy JS, Lustigman S, Yang GJ, Barakat RM, García HH, Sripa B, et al. A research agenda for helminth diseases of humans: diagnostics for control and elimination programmes. PLoS Negl Trop Dis. 2012;6: e1601. doi: 10.1371/journal.pntd.0001601 22545166
19. Solomon AW, Engels D, Bailey RL, Blake IM, Brooker S, Chen JX, et al. A diagnostics platform for the integrated mapping, monitoring, and surveillance of neglected tropical diseases: rationale and target product profiles. PLoS Negl Trop Dis. 2012;6: e1746. doi: 10.1371/journal.pntd.0001746 22860146
20. Knopp S, Becker S, Ingram K, Keiser J, Utzinger J, Diagnosis and treatment of schistosomiasis in children in the era of intensified control. Expert Rev Anti Infect Ther. 2013;11: 1237–1258. doi: 10.1586/14787210.2013.844066 24127662
21. Bergquist R, Yang GJ, Knopp S, Utzinger J, Tanner M, Surveillance and response: tools and approaches for the elimination stage of neglected tropical diseases. Acta Trop. 2015;141: 229–234. doi: 10.1016/j.actatropica.2014.09.017 25301340
22. Utzinger J, Becker SL, van Lieshout L, van Dam GJ, Knopp S. New diagnostic tools in schistosomiasis. Clin Microbiol Infect. 2015 Apr 2. pii: S1198-743X(15)00378-X. doi: 10.1016/j.cmi.2015.03.014
23. Polman K, de Vlas SJ, Gryseels B, Deelder AM, Relating serum circulating anodic antigens to faecal egg counts in Schistosoma mansoni infections: a modelling approach. Parasitology. 2000;121 Pt 6: 601–610. 11155931
24. Corstjens PLAM, van Lieshout L, Zuiderwijk M, Kornelis D, Tanke HJ, Deelder AM, et al. Up-converting phosphor technology-based lateral flow assay for detection of Schistosoma circulating anodic antigen in serum. J Clin Microbiol. 2008;46: 171–176. 17942645
25. Downs JA, van Dam GJ, Changalucha JM, Corstjens PLAM, Peck RN, de Dood CJ, et al. Association of schistosomiasis and HIV infection in Tanzania. Am J Trop Med Hyg. 2012;87: 868–873. doi: 10.4269/ajtmh.2012.12-0395 23033399
26. van Dam GJ, de Dood CJ, Lewis M, Deelder AM, van Lieshout L, Tanke HJ, et al. A robust dry reagent lateral flow assay for diagnosis of active schistosomiasis by detection of Schistosoma circulating anodic antigen. Exp Parasitol. 2013;135: 274–282. doi: 10.1016/j.exppara.2013.06.017 23850995
27. Corstjens PLAM, de Dood CJ, Kornelis D, Fat EM, Wilson RA, Kariuki TM, et al. Tools for diagnosis, monitoring and screening of Schistosoma infections utilizing lateral-flow based assays and upconverting phosphor labels. Parasitology. 2014;141: 1841–1855. doi: 10.1017/S0031182014000626 24932595
28. Corstjens PLAM, Nyakundi RK, de Dood CJ, Kariuki TM, Ochola E, Karanja DM, et al. Improved sensitivity of the urine CAA lateral-flow assay for diagnosing active Schistosoma infections by using larger sample volumes. Parasit Vectors. 2015; In press.
29. van Dam GJ, Xu J, Bergquist R, de Dood CJ, Utzinger J, Qin ZQ, et al. An ultra-sensitive assay targeting the circulating anodic antigen for the diagnosis of Schistosoma japonicum in a low-endemic area, People's Republic of China. Acta Trop. 2015;141: 190–197. doi: 10.1016/j.actatropica.2014.08.004 25128703
30. van Dam GJ, Odermatt P, Acosta L, Bergquist R, de Dood CJ, Kornelis D, et al. Evaluation of banked urine samples for the detection of circulating anodic and cathodic antigens in Schistosoma mekongi and S. japonicum infections: a proof-of-concept study. Acta Trop. 2015;141: 198–203. doi: 10.1016/j.actatropica.2014.09.003 25225158
31. Knopp S, Mohammed KA, Ali SM, Khamis IS, Ame SM, Albonico M, et al. Study and implementation of urogenital schistosomiasis elimination in Zanzibar (Unguja and Pemba islands) using an integrated multidisciplinary approach. BMC Public Health. 2012;12: 930. doi: 10.1186/1471-2458-12-930 23110494
32. WHO. Accelerating work to overcome the global impact of neglected tropical diseases—a roadmap for implementation. Geneva: World Health Organization; 2012. pp 1–42.
33. Knopp S, Person B, Ame SM, Mohammed KA, Ali SM, Khamis IS, et al. Elimination of schistosomiasis transmission in Zanzibar: baseline findings before the onset of a randomized intervention trial. PLoS Negl Trop Dis. 2013;7: e2474. doi: 10.1371/journal.pntd.0002474 24147165
34. Fleiss JL, Statistical methods for rates and proportions. New York: Wiley; 1981. pp 212–236.
35. OCGS. 2012 Population and housing survey of the United Republic of Tanzania. Population distribution by administrative areas. Dar es Salaam and Zanzibar Town: National Bureau of Statistics and Office of Chief Government Statistician; 2013. pp 1–21.
36. Muthén LK, Muthén BO, Mplus user's guide. Los Angeles: Muthén & Muthén; 2012. pp 1–856.
37. Rindskopf D, Rindskopf W, The value of latent class analysis in medical diagnosis. Stat Med. 1986;5: 21–27. 3961312
38. Ibironke O, Koukounari A, Asaolu S, Moustaki I, Shiff C, Validation of a new test for Schistosoma haematobium based on detection of Dra1 DNA fragments in urine: evaluation through latent class analysis. PLoS Negl Trop Dis. 2012;6: e1464. doi: 10.1371/journal.pntd.0001464 22235360
39. van Smeden M, Naaktgeboren CA, Reitsma JB, Moons KG, de Groot JA, Latent class models in diagnostic studies when there is no reference standard—a systematic review. Am J Epidemiol. 2014;179: 423–431. doi: 10.1093/aje/kwt286 24272278
40. Simel DL, Rennie D, Bossuyt PM, The STARD statement for reporting diagnostic accuracy studies: application to the history and physical examination. J Gen Intern Med. 2008;23: 768–774. doi: 10.1007/s11606-008-0583-3 18347878
41. Colley DG, Bustinduy AL, Secor WE, King CH, Human schistosomiasis. Lancet. 2014;383: 2253–2264. doi: 10.1016/S0140-6736(13)61949-2 24698483
42. Spear RC, Seto EYW, Carlton EJ, Liang S, Remais JV, Zhong B, et al. The challenge of effective surveillance in moving from low transmission to elimination of schistosomiasis in China. Int J Parasitol. 2011;41: 1243–1247. doi: 10.1016/j.ijpara.2011.08.002 21920366
43. Polman K, Diakhate MM, Engels D, Nahimana S, van Dam GJ, Falcão Ferreira ST, et al. Specificity of circulating antigen detection for schistosomiasis mansoni in Senegal and Burundi. Trop Med Int Health. 2000;5: 534–537. 10995094
44. Midzi N, Butterworth AE, Mduluza T, Munyati S, Deelder AM, van Dam GJ, Use of circulating cathodic antigen strips for the diagnosis of urinary schistosomiasis. Trans R Soc Trop Med Hyg. 2009;103: 45–51. doi: 10.1016/j.trstmh.2008.08.018 18951599
45. de Jonge N, de Caluwe P, Hilberath GW, Krijger FW, Polderman AM, Deelder AM, Circulating anodic antigen levels in serum before and after chemotherapy with praziquantel in schistosomiasis mansoni. Trans R Soc Trop Med Hyg. 1989;83: 368–372. 2515625
46. van Lieshout L, de Jonge N, el-Masry N, Mansour MM, Bassily S, Krijger FW, et al. Monitoring the efficacy of different doses of praziquantel by quantification of circulating antigens in serum and urine of schistosomiasis patients. Parasitology. 1994;108: 519–526. 8052507
47. Vinkeles Melchers NV, van Dam GJ, Shaproski D, Kahama AI, Brienen EA, Vennervald BJ, et al. Diagnostic performance of Schistosoma real-time PCR in urine samples from Kenyan children infected with Schistosoma haematobium: day-to-day variation and follow-up after praziquantel treatment. PLoS Negl Trop Dis. 2014;8: e2807. doi: 10.1371/journal.pntd.0002807 24743389
48. Stothard JR, Sousa-Figueiredo JC, Khamis IS, Garba A, Rollinson D, Urinary schistosomiasis-associated morbidity in schoolchildren detected with urine albumin-to-creatinine ratio (UACR) reagent strips. J Pediatr Urol. 2009;5: 287–291. doi: 10.1016/j.jpurol.2008.09.010 19168393
49. Stete K, Krauth SJ, Coulibaly JT, Knopp S, Hattendorf J, Müller I, et al. Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children. Parasit Vectors. 2012;5: 298. doi: 10.1186/1756-3305-5-298 23259435